Physician profile
Ron Caloss
NPI 1932157500
$13,290.11
in general payments reported to CMS, 2019-2025
19 companies · $1,982 in 2025
The $1,982 reported for 2025 was more than what 89% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,653 · 2020: $591 · 2021: $1,720 · 2022: $1,797 · 2023: $1,397 · 2024: $2,150 · 2025: $1,982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,517 · Travel and Lodging: $1,038 · Consulting Fee: $900 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,516.89 |
| Travel and Lodging | $1,037.52 |
| Consulting Fee | $900.00 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $3,074.71 | 2022-2025 | |
| Kls-Martin L.P. | $2,879.65 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $2,465.77 | 2019-2025 | Traumaone |
| Stryker Corporation | $1,607.19 | 2019-2025 | Na, Vsp System, Vsp Cranial, Colorado |
| Alon Medical Technology | $1,228.90 | 2024-2025 | |
| Acumed LLC | $900.00 | 2024 | |
| Straumann USA LLC | $237.24 | 2023 | |
| Depuy Synthes Sales INC. | $234.21 | 2019 | |
| Osteomed LLC | $154.51 | 2021 | |
| Abbvie INC. | $147.46 | 2024 | |
| Axogen | $113.68 | 2019 | |
| Integra Lifesciences Corporation | $83.34 | 2019 | |
| Henry Schein, INC. | $50.76 | 2019-2025 | Nuoss, Nuoss Ds Delivery Syringes |
| Arthrex, INC. | $24.00 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $20.20 | 2023 | Exparel |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18.05 | 2023 | Rhythmia Mapping System |
| Olympus America INC. | $18.00 | 2019 | |
| Geistlich Pharma, North America, INC. | $16.35 | 2019 | |
| Biohorizons Implant Systems INC. | $16.09 | 2024 | Biohorizons |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Caloss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.